Stroke Trial, Recruiting (NCT05653141)

Stroke Trial, Recruiting NCT05653141 Sponsor: Roza Umarova Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT05653141 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years of age or older
You must have had your first-ever stroke (specifically an ischemic stroke affecting the front part of the brain), confirmed by a routine MRI scan
You must be enrolled within 10 days of when your stroke happened

Who may not be able to join:

You have had a previous stroke at any point in the past, either known from your medical history or seen on brain scans
You have also had a stroke in the back part of the brain (posterior circulation) in addition to the front
You have a condition that would make it difficult to complete memory and thinking tests, such as confusion, being on a breathing machine, or being very difficult to wake (confirm with trial site)
You have a neurological or mental health condition that could affect how test results are understood — for example, dementia before the stroke, schizophrenia, a brain tumor, regularly taking a type of sedative medication called benzodiazepines, or depression
You are unable to have an MRI scan for any reason (for example, having a certain type of metal implant)
Your native language is not German, French, or Italian

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Roza M. Umarova, PD Dr., Department of Neurology, Inselspital, University Hospital Bern, University of Bern

Phone: +41316327000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05653141

Sponsor: Roza Umarova

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: +41316327000

More information: https://clinicaltrials.gov/study/NCT05653141

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years of age or older
You must have had your first-ever stroke (specifically an ischemic stroke affecting the front part of the brain), confirmed by a routine MRI scan
You must be enrolled within 10 days of when your stroke happened

Who may not be able to join:

You have had a previous stroke at any point in the past, either known from your medical history or seen on brain scans
You have also had a stroke in the back part of the brain (posterior circulation) in addition to the front
You have a condition that would make it difficult to complete memory and thinking tests, such as confusion, being on a breathing machine, or being very difficult to wake (confirm with trial site)
You have a neurological or mental health condition that could affect how test results are understood — for example, dementia before the stroke, schizophrenia, a brain tumor, regularly taking a type of sedative medication called benzodiazepines, or depression
You are unable to have an MRI scan for any reason (for example, having a certain type of metal implant)
Your native language is not German, French, or Italian

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Roza Umarova

Registry

ClinicalTrials.gov

Start date

17 December 2020

Est. completion

31 October 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Number of participants with delayed cognitive deterioration (DCD); Number of participants with delayed functional deterioration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov